New diabetes clinical trial: A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Published on: April 28, 2025 at 11:00PM
Conditions: Healthy Participants
Interventions: Drug: AZD5004; Drug: Rosuvastatin; Drug: Erythromycin; Drug: Atorvastatin; Drug: Simvastatin; Drug: Repaglinide
Sponsors: AstraZeneca
Not yet recruiting
https://ift.tt/hnJMxbK